Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44343 clinical trials with a EudraCT protocol, of which 7372 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,343)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

44,343 result(s) found. Displaying page 1,842 of 2,218.

EudraCT Number: 2018-001606-29

Sponsor Protocol Number: INCB39110-309

Start Date*: 2019-04-03

Sponsor Name:Incyte Corporation

Full Title: GRAVITAS-309: A Phase 2/3 Study of Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Medical condition: Moderate or severe cGVHD

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10021428 - Immune system disorders	10066261	Chronic graft versus host disease	PT
	20.1	10021428 - Immune system disorders	10072160	Chronic graft versus host disease in liver	PT
	20.1	10021428 - Immune system disorders	10072158	Chronic graft versus host disease in intestine	PT
	20.1	10021428 - Immune system disorders	10072159	Chronic graft versus host disease in skin	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) GB (GB - no longer in EU/EEA) FR (Ongoing) SE (Completed) DE (Prematurely Ended) PL (Completed) DK (Completed) ES (Temporarily Halted) GR (Prematurely Ended) FI (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2021-002844-66

Sponsor Protocol Number: INCB50465-309

Start Date*: 2022-05-30

Sponsor Name:Incyte Corporation

Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Parsaclisib in Participants with Primary Warm Autoimmune Hemolytic Anemia (PATHWAY)

Medical condition: Primary Warm Autoimmune Hemolytic Anemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004851	10003825	Autoimmune hemolytic anemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) AT (Completed) IT (Completed) ES (Ongoing) NL (Completed) HU (Completed) FR (Completed)

Trial results: View results

EudraCT Number: 2015-005300-29	Sponsor Protocol Number: SDF1	Start Date*: 2016-06-06
Sponsor Name:Malmö University, Faculty of Odontology
Full Title: Prevention and treatment of initial rotcaries among elderly in Skåne.
Medical condition: Dental caries
Disease:
Population Age: Elderly		Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results

EudraCT Number: 2020-004780-71	Sponsor Protocol Number: PROFERTIL	Start Date*: Information not available in EudraCT
Sponsor Name:Karolinska University Hospital
Full Title: A phase III Randomized Double-Blinded Placebo-Controlled Study of Use of GnRHa during Chemotherapy for Fertility Protection of Young Women and Teenagers with Cancer - ProFertil
Medical condition: Breast Cancer Acute Leukemia Lymphomas (Hodgkin and non-Hodgkin) Sarcomas (Osteo, Soft tissue and Ewing)
Disease:
Population Age: Adolescents, Under 18, Adults		Gender: Female
Trial protocol: SE (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2022-001611-50

Sponsor Protocol Number: S67072

Start Date*: 2022-11-15

Sponsor Name:UZ Leuven

Full Title: Patient reported efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease

Medical condition: Aspirin-Exacerbated Respiratory Disease (AERD) in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	25.1	100000004855	10075084	Aspirin-exacerbated respiratory disease	LLT

Population Age: Elderly

Gender: Male, Female

Trial protocol: BE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-003162-41

Sponsor Protocol Number: SGZ-2018-12012

Start Date*: 2021-02-10

Sponsor Name:Klinikum rechts der Isar, Technische Universität München

Full Title: An investigator-initiated, multi-center, randomized, double-blind, placebo controlled study of Dupilumab to demonstrate efficacy in subjects with nummular eczema

Medical condition: Subjects with nummular eczema

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10040785 - Skin and subcutaneous tissue disorders	10012431	Dermatitis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-000355-40

Sponsor Protocol Number: SOLARIS

Start Date*: 2021-09-20

Sponsor Name:Frankfurter Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Full Title: SOLARIS – A phase-II open-label study of pembrolizumab and lenvatinib in patients with advanced stage hepatocellular carcinoma who are refractory to atezolizumab and bevacizumab/ IO-based therapy

Medical condition: advanced stage hepatocellular carcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10073069	Hepatic cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2020-002683-31

Sponsor Protocol Number: TUD-ALPINE-077

Start Date*: 2021-06-24

Sponsor Name:Technische Universität Dresden

Full Title: A Phase II, single-arm trial of Atezolizumab/Platinum/Etoposide for the treatment of advanced large-cell neuroendocrine cancer of the lung

Medical condition: locally advanced or metastatic large-cell neuroendocrine carcinoma of the lung (LCNEC) not eligible for curative treatment

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10078184	Neuroendocrine tumor of the lung metastatic	LLT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10078175	Neuroendocrine tumour of the lung metastatic	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-004411-11

Sponsor Protocol Number: NeoTreme

Start Date*: 2023-05-03

Sponsor Name: University Hospital Schleswig-Holstein, Campus Lübeck

Full Title: Phase 2 Study of Preoperative Gemcitabine Plus Cisplatin with Durvalumab (MEDI4736) and Tremelimumab in intrahepatic cholangiocarcinoma (NeoTreme)

Medical condition: Intrahepatic cholangiocarcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	27.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10073077	Intrahepatic cholangiocarcinoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2020-004132-22

Sponsor Protocol Number: NPH-01

Start Date*: 2021-01-20

Sponsor Name:Uppsala University Hospital

Full Title: Double-blind randomized acetazolamide trial in normal pressure hydrocephalus

Medical condition: Normal pressure hydrocephalus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029205 - Nervous system disorders	10020510	Hydrocephalus acquired	LLT

Population Age: Elderly

Gender: Male, Female

Trial protocol: SE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-006674-22

Sponsor Protocol Number: 56021927PCR2046

Start Date*: 2022-12-12

Sponsor Name:VÝCHODOSLOVENSKÝ ONKOLOGICKÝ ÚSTAV, a.s.

Full Title: AD ASTRA (Androgen Deprivation with Apalutamide and STereotactic RAdiotherapy) Prospective institutional phase II study of efficacy and safety of androgen deprivation with apalutamide in high-risk ...

Medical condition: Localized or a locally advanced high-risk prostate cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10060862	Prostate cancer	PT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: SK (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-001188-58	Sponsor Protocol Number: IDIT001	Start Date*: 2022-02-16
Sponsor Name:Göteborgs Universitet
Full Title: The effect of anti-IL17 in new-onset type 1 diabetes: a randomized, double-blind, placebo-controlled trial
Medical condition: Type 1 diabetes
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: SE (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2019-000374-39

Sponsor Protocol Number: ORARIALS-02

Start Date*: 2019-07-15

Sponsor Name:Orphazyme A/S

Full Title: Open-label, Non-randomised Extension Trial to Assess the Long-Term Safety and Efficacy of 1200 mg/day Arimoclomol 400 mg Three Times a Day (t.i.d.) in Subjects with Amyotrophic Lateral Sclerosis (A...

Medical condition: Amyotrophic Lateral Sclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10029205 - Nervous system disorders	10002026	Amyotrophic lateral sclerosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) SE (Completed) BE (Completed) PL (Completed) DE (Completed) NL (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2020-004614-35

Sponsor Protocol Number: ECO-02

Start Date*: 2021-11-23

Sponsor Name:Ismail Gögenur

Full Title: Treatment with SGLT-2 inhibitor for postoperative hyperglycemia in acute abdominal surgery – a randomized trial

Medical condition: Postoperative (stress) hyperglycemia in patients with no known diabetes after acute abdominal surgery

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	24.0	100000004861	10042216	Stress induced hyperglycemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2015-002437-21

Sponsor Protocol Number: GEICAM/2014-12

Start Date*: 2015-11-09

Sponsor Name:GEICAM (Spanish Breast Cancer Research Group Foundation)

Full Title: A randomized, double-blind, parallel-group, multicentre, phase II study to compare the efficacy and tolerability of fulvestrant (FaslodexTM) 500mg with placebo and fulvestrant (FaslodexTM) 500mg in...

Medical condition: Postmenopausal women presenting with HR-positive/HER2-negative metastatic breast cancer who have received at least 5 years of endocrine therapy in the adjuvant setting as treatment for early diseas...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	100000004864	10027475	Metastatic breast cancer	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Ongoing) IE (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-000244-10	Sponsor Protocol Number: EGBAB	Start Date*: 2019-12-13
Sponsor Name:Region Uppsala
Full Title: Influence of antibiotic treatment on the normal flora and the presence of resistance genes in known carriers of ESBL and VRE
Medical condition: Carriage of genes coding for vancomycin resistant enterococci (VRE) and extended spectrum betalactamase producing enterobacteriales (EPE) phenotypes.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2021-002027-38	Sponsor Protocol Number: SOLTI-2101	Start Date*: 2022-02-11
Sponsor Name:SOLTI
Full Title: A Phase III, multicenter, open-label study of ribociclib vs. palbociclib in patients with advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer - HARMONIA trial
Medical condition: Patients with advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Ongoing) PT (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2020-005177-27

Sponsor Protocol Number: 2020-005177-27

Start Date*: 2021-09-22

Sponsor Name:Bispebjerg Hospital

Full Title: Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy

Medical condition: Topical local anesthesia for upper gastrointestinal endoscopy

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	100000004865	10024760	Local anesthetic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2020-002593-27	Sponsor Protocol Number: S64291	Start Date*: 2022-06-17
Sponsor Name:UZ Leuven
Full Title: Budesonide as a treatment for low-grade duodenal inflammation in functional dyspepsia.
Medical condition: Functional dyspepsia
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2021-006931-25

Sponsor Protocol Number: N/A

Start Date*: 2022-03-24

Sponsor Name:Bispebjerg and Frederiksberg Hospital, University of Copenhagen

Full Title: Efficacy and safety of oral roflumilast in the treatment of palmoplantar pustulosis – a randomised controlled trial

Medical condition: Palmoplantar pustulosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	100000004858	10037158	Psoriasis palm & soles	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Sat Jun 14 19:32:04 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA